JERUSALEM, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key business updates for the quarter ended June 30, 2025.
WASHINGTON, Aug. 8, 2025 /PRNewswire/ -- The U.S. Postal Service filed notice today with the Postal Regulatory Commission (PRC) regarding a temporary price change for...
WASHINGTON, Aug. 8, 2025 /PRNewswire/ -- Growth Energy—the leading voice of America's biofuel industry—is commemorating the 20th anniversary of the Renewable Fuel Standard (RFS), which...
Initiated rolling NDA submission for zidesamtinib for TKI pre-treated patients with advanced ROS1-positive NSCLC, with target completion in the third quarter of 2025
Initiated ALKAZAR...
Presentations showcased at World Transplant Congress in San Francisco demonstrate HOPE reduces the cost of liver transplantation by shortening the index hospitalization and decreasing...
DELRAY BEACH, Fla., Aug. 6, 2025 /PRNewswire/ -- The report "Asphalt Additive Market by Type (Polymeric Modifiers, Anti-Strip & Adhesion Promoters, Emulsifiers, Chemical Modifiers, Rejuvenators, Fibers,...
DELRAY BEACH, Fla., Aug. 6, 2025 /PRNewswire/ -- The report "Asphalt Additive Market by Type (Polymeric Modifiers, Anti-Strip & Adhesion Promoters, Emulsifiers, Chemical Modifiers, Rejuvenators, Fibers,...